Yamamoto N - Search Results

1

Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.

Kawamura I, Lacey E, Yamamoto N, Sakai F, Takeshita S, Inami M, Nishigaki F, Naoe Y, Tsujimoto S, Manda T, Shimomura K, Goto T. Kawamura I, et al. Among authors: yamamoto n. Anticancer Res. 1999 Sep-Oct;19(5B):4105-11. Anticancer Res. 1999. PMID: 10628361

2

Effect of lipoprotein lipase activators bezafibrate and NO-1886, on B16 melanoma-induced cachexia in mice.

Kawamura I, Yamamoto N, Sakai F, Yamazaki H, Goto T. Kawamura I, et al. Among authors: yamamoto n. Anticancer Res. 1999 Sep-Oct;19(5B):4099-103. Anticancer Res. 1999. PMID: 10628360

3

Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice.

Yamamoto N, Kawamura I, Nishigaki F, Tsujimoto S, Naoe Y, Inami M, Elizabeth L, Manda T, Shimomura K. Yamamoto N, et al. Anticancer Res. 1998 Jan-Feb;18(1A):139-44. Anticancer Res. 1998. PMID: 9568068

4

Activation of lipoprotein lipase and inhibition of B16 melanoma-induced cachexia in mice by ponalrestat, an aldose reductase inhibitor.

Kawamura I, Yamamoto N, Sakai F, Yamazaki H, Naoe Y, Inami M, Manda T, Shimomura K. Kawamura I, et al. Among authors: yamamoto n. Anticancer Res. 1999 Jan-Feb;19(1A):341-8. Anticancer Res. 1999. PMID: 10226565

5

FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-alpha, ameliorates endotoxin-induced shock.

Yamamoto N, Sakai F, Yamazaki H, Sato N, Nakahara K, Okuhara M. Yamamoto N, et al. Eur J Pharmacol. 1997 May 30;327(2-3):169-74. doi: 10.1016/s0014-2999(97)89657-4. Eur J Pharmacol. 1997. PMID: 9200556

6

Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.

Yamamoto N, Sakai F, Yamazaki H, Kawai Y, Nakahara K, Okuhara M. Yamamoto N, et al. J Rheumatol. 1996 Oct;23(10):1778-83. J Rheumatol. 1996. PMID: 8895158

7

Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation.

Yamamoto N, Sakai F, Yamazaki H, Nakahara K, Okuhara M. Yamamoto N, et al. Eur J Pharmacol. 1996 Oct 24;314(1-2):137-42. doi: 10.1016/s0014-2999(96)00537-7. Eur J Pharmacol. 1996. PMID: 8957229

8

Preischemic and postischemic treatment with a new Na+/H+-exchange inhibitor, FR183998, shows cardioprotective effects in rats with cardiac ischemia and reperfusion.

Ohara F, Sugimoto T, Yamamoto N, Ohkubo K, Maeda K, Ozaki T, Seki J, Goto T. Ohara F, et al. Among authors: yamamoto n. J Cardiovasc Pharmacol. 1999 Dec;34(6):848-56. doi: 10.1097/00005344-199912000-00012. J Cardiovasc Pharmacol. 1999. PMID: 10598129

9

Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent.

Yamamoto N, Nomura M, Okubo K, Maeda K, Goto T. Yamamoto N, et al. J Cardiovasc Pharmacol. 1999 Apr;33(4):587-94. doi: 10.1097/00005344-199904000-00011. J Cardiovasc Pharmacol. 1999. PMID: 10218729

10

Protective effect of FR183998, a Na+/H+ exchange inhibitor, against postischemic injury after normothermic and prolonged hypothermic ischemia in isolated perfused rat hearts.

Ohara F, Yamamoto N, Maeda K, Ozaki T, Seki J, Goto T. Ohara F, et al. Among authors: yamamoto n. Jpn J Pharmacol. 2001 Oct;87(2):110-6. doi: 10.1254/jjp.87.110. Jpn J Pharmacol. 2001. PMID: 11700009 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,414 results

Search Page

Filters